SCHEMBL28768290

SCHEMBL28768290

NC(=O)OC1CCOc2cc(SBr)ccc21

nearest known ligand 0.34

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.34
▸ MAP3K14 Q99558 1/20 0.34
▸ POLB P06746 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ KDM4C Q9H3R0 8/20 0.32
▸ KDM6B O15054 3/20 0.32
▸ NPC1 O15118 1/20 0.31
▸ TP53 P04637 1/20 0.31
▸ PKM P14618 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ LMNA P02545 1/20 0.30
▸ ATM Q13315 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28768366 0.90 TSHR (0.34) TSHRPOLBTDP1NPC1TP53
SCHEMBL28768386 0.83 ADRA2A (0.42) TSHRMAP3K14POLBTDP1KDM4C
SCHEMBL28943661 0.81 TSHR (0.42) TSHRKDM4CKDM6BNPC1TP53
SCHEMBL28768183 0.81 MAP3K14 (0.40) MAP3K14POLBKDM4CKDM6B
SCHEMBL28768211 0.81 KDM4C (0.49) KDM4CKDM6BNPC1RAB9ASMN1; SMN2
SCHEMBL28768120 0.79 SMYD3 (0.36) KDM4CKDM6B
SCHEMBL28768046 0.79 MGLL (0.39) KDM4CKDM6B
SCHEMBL28768266 0.79 MAP3K14 (0.41) MAP3K14TDP1KDM4CKDM6BLMNA
SCHEMBL28768200 0.78 TSHR (0.43) TSHRPOLBNPC1TP53RAB9A
SCHEMBL23362844 0.75 MAP3K14 (0.37) MAP3K14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114641477-B Compounds having inhibitory activity on glucosylceramide synthase or pharmaceutically acceptable salts thereof and pharmaceutical compositions containing the same 柳韩洋行 2024-03-12 — — CN disclosed
CN-114641477-A Novel compound having inhibitory activity against glucose ceramide synthase or pharmaceutically acceptable salt thereof, method for preparing same, and pharmaceutical composition comprising same 柳韩洋行 2022-06-17 — — CN disclosed
Send feedback